Two Sigma Investments, LP Viracta Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.38 - $2.29 $62,410 - $103,565
-45,225 Reduced 75.66%
14,549 $23,000
Q4 2022

Feb 14, 2023
BUY
$1.26 - $4.38 $75,315 - $261,810
59,774 New
59,774 $87,000
Q1 2022

May 16, 2022
SELL
$2.23 - $4.76 $355,308 - $758,415
-159,331 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$3.37 - $7.91 $536,945 - $1.26 Million
159,331 New
159,331 $582,000

Others Institutions Holding VIRX

# of Institutions
43
Shares Held
9.39M
Call Options Held
5.9K
Put Options Held
0
View Full List

About Viracta Therapeutics, Inc.

VIRX Quotes by TradingView
  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $18.4M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email